drugset / Trial / NCT00184756

Efficacy on Height in SGA Children Treated With Growth Hormone

NCT00184756

Phase 3 Completed 151 enrolled Novo Nordisk A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial is conducted in Europe and Middle East. Growth hormone in SGA Children This trial compares a treated group of patients with an untreated group of patients.

Timeline

Start
2002-11
Primary completion
2006-07
Completion
2006-07

Publications

  • Results Phillip M, Lebl J, Zuckerman-Levin N, Korpal-Szczyrska M, Sales Marques J, Ibáñez L on behalf of the European Norditropin SGA study group. Multinational study in short SGA children: evaluation of the effect of three different growth hormone dose regimens. European Society for Paediatric Endocrinology (ESPE) 2007; Country: Finland City: Helsinki

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic